Rare Dermatology

Rare Dermatology

Rare Dermatology Greg Licholai, MD Chief Medical Information Officer SEPTEMBER 20, 2018 Rare dermatological diseases are under-represented in drug development and pharmaceutical company-sponsored trials — only about one-tenth of non-oncology rare dermatological...
Rare Diseases Newsletter: April 2018

Rare Diseases Newsletter: April 2018

Rare Diseases Newsletter: April 2018 Scott Schliebner VP, Scientific Affairs JANUARY 10, 2018 With only 5% of rare diseases having even one approved treatment option, millions of patients around the globe are left without treatment. However, advanced therapies hold...
Rare Diseases Newsletter: January 2018

Rare Diseases Newsletter: January 2018

Rare Diseases Newsletter: January 2018 Scott Schliebner VP, Scientific Affairs JANUARY 10, 2018 There are two broad categories of Hemolytic Uremic Syndromes (HUS), typical HUS and atypical HUS (aHUS), both of which cause a rare and devastating disease. Read about aHUS...
The Changing Landscape of ADME Studies

The Changing Landscape of ADME Studies

The Changing Landscape of ADME Studies Ad F. Roffel, Ph.D. Director of Scientific Affairs – Clinical Pharmacology DECEMBER 7, 2017 In September, Ad F. Roffel, Ph.D., Director of Scientific Affairs – Clinical Pharmacology, presented in Munich, Germany on The...